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Abstract  
Background & Aim: The outputs of physiological systems fluctuate in a complex manner even under 
resting conditions.  Decreased variability or increased regularity of these outputs is documented in several 
disease states.  Changes are observed in the spatial and temporal configuration of the electroencephalogram 
(EEG) in patients with hepatic encephalopathy (HE), but there is no information on the variability of the 
EEG signal in this condition.  The aim of this study was to measure and characterize EEG variability in 
patients with cirrhosis and to determine its relationship to neuropsychiatric status.  
Methods: Eyes-closed, awake EEGs were obtained from 226 patients with cirrhosis, classified, using 
clinical and psychometric criteria, as neuropsychiatrically unimpaired (n=127) or as having minimal (n=21) 
or overt (n=78) HE, and from 137 healthy controls.  Analysis of EEG signal variability was undertaken 
using continues wavelets transform and sample entropy.  
Results: EEG variability was reduced in the patients with cirrhosis compared to healthy controls 
(coefficient of variation: 21.2% [19.3-23.4] vs. 22.4% [20.8-24.5]; p<0.001).  A significant association was 
observed with neuropsychiatric status; EEG variability was increased in patients with minimal HE 
compared with their neuropsychiatrically unimpaired counterparts (sample entropy: 0.98 [0.87-1.14] vs. 
0.83 [0.75-0.95]; p=0.02), while it was suppressed in the patients with overt HE compared to those with 
minimal HE (sample entropy: 0.82 [0.71-1.01] vs. 0.98 [0.87-1.14]; p=0.01). 
Conclusion: Variability of the EEG is associated with both the presence and severity of HE.  This novel 
finding may provide new insights to the pathophysiology of HE and provide a means for monitoring 
patients over time.  
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Introduction  
Hepatic encephalopathy (HE) is a common and potentially disabling complication of chronic liver disease.  
It reflects a continuum of neuropsychiatric abnormalities ranging from discrete impairment of executive 
brain functions to profound coma [1].  The development of HE, compromises daily living activities and 
reduces patients’ life quality and has a significant negative effect on survival [2–5].  Nevertheless, there is 
still no ‘gold standard’ for the diagnosis of this syndrome and in particular the diagnosis of minimal HE 
remains difficult to establish due to the discrete cognitive abnormalities characterising the lower end of the 
HE spectrum [1].  
 
The electroencephalogram (EEG) reflects cortical neuronal activity and has been used to facilitate the 
diagnose of HE since the early 1950s [6].  The main electrophysiological characteristic of HE is slowing of 
the mean frequency from the alpha range towards the theta and delta ranges [7].  The diagnostic efficacy of 
the EEG, in this situation, is difficult to gauge because: (i) there is no diagnostic gold standard for 
comparison, and: (ii) result may vary depending on whether reports are based on visual inspection or 
spectral analysis.  Thus, there is considerable variation in the reported performance of the EEG, with 
sensitivities, for the diagnosis of overt HE, ranging from 43 to 100% and specificities ranging from 41 to 
88% [7]. 
 
A number of other EEG features have been observed in patients with HE including, transient fast activities 
[7]; distinct topographic changes over the temporal and frontal cortical [7]; and dissociation and 
anteriorisation of the posterior basic rhythm with disease progression [8–11].  However, the predominant 
use of frequency estimates, for diagnostic purposes, has resulted in a relative disregard of these other EEG 
characteristics and hence little is known about their importance or diagnostic utility. 
 
The EEG signal, like many physiological time series, is complex, as the information contained within the 
signal comprises a multitude of fast and slow frequencies with changing potentials.  In addition, and 
contrary to classical concepts of physiological control, the output fluctuates in a complex manner, even in 
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the resting state [12].  Deceased variability or increased regularity of a number of physiological rhythms 
has been reported in different clinical settings and associates with disease severity and negative outcomes 
[13].  It has been shown, for example, that the complexity of the EEG decreases up to 25 min before an 
epileptic seizure [14] and that the complexity of the EEG decreases in Alzheimer’s disease [15].   
 
The advent of mathematical techniques with a basis in chaos theory and nonlinear dynamics and the parallel 
advancements in computational methodology have facilitated the measurement and characterization of the 
variability and complexity of time series [16]. Continuous wavelet transform (CWT) and sample entropy 
are techniques, which, in addition to conventional spectral analysis, can be used to characterise variability 
and transient features of the EEG [10,17–19].  CWT has better time-frequency resolution than Fast Fourier 
Transform [19], the technique most often employed for spectral analysis of the EEG.  Sample entropy can 
be used to investigate the temporal dynamics of the EEG; it quantifies the degree of regularity vs. the 
degree of unpredictability of the signal and thus provided a measure of its variability [18].  Regular time 
series are characterized by low sample entropy while random time series, which have greater disorder and 
complexity, are characterized by high sample entropy.   
 
The aims of the present study were: 1) to characterise EEG rhythmicity and its topography based on CWT 
spectral analysis; 2) to characterise the variability of the EEG signal using dynamic CWT estimates and 
sample entropy; and, 3) to investigate possible interactions between EEG variability measures, 
neuropsychiatric status, and the aetiology and severity of the underlying liver disease. 
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Subjects and Methods  
Study populations 
The patient population comprised of 226 patients (149 men: 77 women; mean [range] age 54.8 [26-80] 
years) with biopsy-proven cirrhosis recruited at the Royal Free Hospital, London between 2008 and 2012.  
The aetiology of the liver injury was determined using clinical, laboratory, radiological and histological 
variables, whilst its severity was assessed using the model for end-stage liver disease (MELD) score and 
Pugh modification of the Child’s grading system [20].  All patients were clinically stable at the time of the 
study.  Patients were excluded if they were under 25 or over 80 years of age; if they had suffered an episode 
of major hepatic decompensation within seven days of the assessment date; had hyponatraemia or renal 
failure; had significant cardiac or respiratory failure; insulin-dependent diabetes mellitus or non-insulin 
dependent diabetes with poor glycaemic control; cerebrovascular disease; epilepsy; a history of significant 
head injury or other conditions likely to affect cerebral function.  Patients were also excluded if they had 
misused alcohol or drugs in the previous three months or were taking psychoactive medications, including 
hypnotic drugs. 
 
The reference population of 137 healthy volunteers (73 men: 64 women: mean age 38 [17-75] years) was 
recruited from amongst family, friends and staff working at the Royal Free Hospital, London and 
individuals who had experienced an isolated episode of fainting/dizziness but in whom clinical 
examination, the EEG, and cerebral imaging were completely normal.  None had a history of liver disease, 
drank alcohol in excess of 20 g daily, took prescription or over-the-counter medications. 
 
The study was conducted according to the Declaration of Helsinki (Hong Kong Amendment) and Good 
Clinical Practice (European guidelines). The protocol was approved the Royal Free Hampstead NHS Trust 
Ethics Committee.  All participating subjects, or their appropriately appointed guardian, provided written, 
informed consent. 
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Overall Study Procedures 
Each recruited subject was assessed in a single session lasting approximately two hours.  All assessments, 
apart from the EEG, were completed, in a quiet and well-lit room.  The EEGs were performed in a 
dedicated recording room by a trained neurophysiologist.  The procedures were carried out in the same 
order using a standard set of instructions from scripted texts. 
 
(i). Mental State and Psychometric Assessment: Patients were clinically assessed by two hepatologists, 
working independently, and their mental state classified, using West Haven Criteria [21], as either clinically 
unimpaired or as showing features of overt HE.  Psychometric performance was assessed using the 
Psychometric Hepatic Encephalopathy Score (PHES) battery [22], which comprises five paper and pencil 
tests viz: digit symbol, number connection A and B, serial dotting, and line tracing, which has both time and 
error components. The PHES data were adjusted and scored using UK normative reference data [23].  
Composite scores of less than two standard deviations below mean reference values were considered 
abnormal.   
 
 (ii). EEG Recording: Electroencephalograms (EEGs) were recorded on one of two digital EEG systems, 
Walter-Graphtek PL-Winsor (Walter-Graphtek GmbH, Emmendingen, Gerrmany) or MicroMed 
SystemPlus EVOLUTION (Micromed Sp.A., Mogliano, Veneto, Italy). Recordings were undertaken for six 
minutes, in a state of eyes-closed, relaxed, wakefulness, using 23 silver-silver chloride electrodes placed 
according to the International 10-20 System.  The impedance of the electrodes was kept below 5 KΩ.   
 
Classification of Neuropsychiatric Status 
Neuropsychiatric status was classified, on the day of the study, as: (i) unimpaired: no clinical evidence of 
HE and no psychometric abnormalities; (ii) minimal HE: no clinical abnormalities but impaired 
psychometric performance, defined supra vide; (iii) overt HE: clinically evident, characteristic 
neuropsychiatric disturbances.   
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EEG Analysis 
(i). EEG pre-processing: A consecutive, 60–100 seconds of eye-closed, artefact-free recording was selected 
from all suitable recordings for EEG analysis.  If an insufficient length of artefact-free recoding were 
available the selection criteria were relaxed to include sections that were artefact-free on the P3-P4 
derivation.   
 
(ii). CWT spectral and variability estimates: CWT is based on a mother wavelet function, which can be 
translated and dilated to calculate time-frequency coefficients.  The mother wavelet function can be chosen 
from a set of infinite functions.  For purposes of this study a complex Morlet wavelet function with a 
bandwidth of 10 Hz and a centre frequency of 1 Hz was used.  Scales for the mother wavelet were chosen 
to match frequencies ranging from 1-32 Hz with a 0.5 Hz between-scale frequency interval.  The wavelet 
coefficients were divided into standardized frequency bands viz: delta (1–4 Hz), theta (4–8 Hz), alpha (8–12 
Hz) and beta (12–32 Hz) and averaged over time; the scales contained within each frequency band were 
summated to provide a measure of the absolute activity.  The relative activity was calculated separately for 
each channel by dividing individual frequency band with the summated energy for all bands and 
multiplying by 100.  EEG variability was calculated as the Coefficient of Variation (CV) for the wavelet 
coefficients.  Hence, for each frequency band successive epochs of 2s were extracted from the CWT output 
and the CV was calculated as the standard deviation of the wavelet coefficient divided by the its mean  of 
the wavelet coefficientusing Matlab 2012a (The Matworks, Inc., Natick, MA, USA).  The average CV 
across all frequency bands was reported used to obtain provide a single measure of EEG variability. Matlab 
2012a (The Matworks, Inc., Natick, MA, USA) was used for analysis. 
 
(iii). Sample entropy: Sample entropy provides a measure of disorder or randomness and hence system 
complexity [18].  It is defined as the logarithmic likelihood of the repetition of patterns in a time series and 
estimates the probability that an epoch of window length m, with a degree of tolerance r, will be repeated at 
later time points.  Calculation of sample entropy was undertaken using Matlab 2012a (The Matworks, Inc., 
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Natick, MA, USA) with values for m fixed at 2 ms and r at 0.2 ms.  The average sample entropy across all 
frequency bands was used to provide a single measure for analysis. 
 
Data processing and statistical analysis 
The distribution of variables was tested by visual inspection of QQ-plots and the assumption of variance 
homogeneity was checked by the Levene`s test.  The potential confounding effects of gender and age on 
EEG variables were assessed in the reference population using linear regression and the necessary 
adjustments applied to the patients’ EEG variables prior to the main statistical analysis.  A grand mean 
across all electrodes was calculated for the spectral and variability EEG measures.  Differences between 
normally distributed EEG variables were examined by one-way ANOVA with subsequent between group 
comparisons performed with the Tukey HSD (Honest Significant Difference) test.  Differences between 
non-normally distributed variables were examined using the Kruskal-Wallis test with subsequent between-
groups comparisons performed using the Mann-Whitney U or Dunn's Pairwise Comparison test with 
Bonferroni corrections applies for multiple comparisons.  Univariate logistic regression analysis was used 
to examine the relationship between the aetiology and severity of the liver disease, the presence of 
clinically overt HE and the PHES score and the two EEG variability measures.  All four variables were 
included in multivariate analyses.  All reported P values were two-tailed with value less than 0.05 
considered significance. The software package STATA version 11.2 (StataCorp LP, College Station, 
Texas) and R version 3.0.2 (CRAN.R-project.org/doc/FAQ/R-FAQ.html) were utilized. 
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Results  
Patient Population 
The aetiology of the cirrhosis was alcohol in 157 (69.5%) of the 226 patients; alcohol and hepatitis C/B 
virus (HCV/HBV) infection in 21 (9.3%); cryptogenic in 12 (5.3%); fatty liver disease in 11 (4.9%); 
HCV/HBV infection in eight (3.5%); primary biliary cirrhosis in six (2.7%); chronic active hepatitis in five 
(2.2%); haemochromatosis in two (0.9%); and ‘other’ in four (1.8%).  Functionally: 135 (59.7%) of the 
patients were classified as Child’s Grade A; 51 (22.6%) as Child’s Grade B; and 40 (17.7%) as Child’s 
Grade C (Table 1).   
 
On the day of study: 127 (56.2 %) of the 226 patients were classified as neuropsychiatrically unimpaired, 
21 (9.3%) as having minimal and 78 (34.5%) as having overt HE (Table 1).  None of the patients classified 
as neuropsychiatrically unimpaired or as having minimal HE had a history of previous overt HE; 50% of 
those classified as having overt HE had documented evidence of previous, clinically apparent, 
neuropsychiatric impairment.  The patients with overt HE had, as expected, significantly less functional 
hepatic reserve than the patients in the other two groups, evidenced by their higher mean MELD and 
Pugh’s score; they also showed a significantly greater degree of psychometric impairment (Table 1). The 
distributions of patients in the alcohol-related and non alcohol-related groups were proportionate in relation 
to the degree of neuropsychiatric impairment (unimpaired 93 [59%] vs. 21 [44%], minimal HE 12 [8%] vs. 
7 [15%] and overt HE 52 [33%] vs. 20 [42%]; p=0.12 respectively). 
 
The reference population were significantly younger than the patients; there were no significant differences 
in age between the patient subgroups (Table 1).  
 
Spectral EEG analysis 
A total of 226 EEGs were recorded in patients with cirrhosis and 137 in the reference population; none was 
discarded because of abnormal focal activity.  Analysable data were available from all patient and reference 
EEGs. 
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Compared to the reference population, the patients with cirrhosis had higher median (interquartile range) 
activities in the theta band (16.8% [14.1-21.4] vs. 15.2% [13.6-17.0]; p<0.0001) and decreased activities in 
the alpha band (21.4% [16.9-26.3] vs. 23.2% [18.0-28.9]; p=0.03).  
 
A significant slowing of the EEG was observed in the patients with overt HE compared to those who were 
neuropsychiatrically unimpaired and those with minimal HE.  This was evidenced by increased theta 
activity (22.9% [17.1-27.6] vs.15.4% [13.6-18.0] vs. 16.3% [13.6-17.5] p<0.001) and decreased alpha 
(18.7% [15.6-22.4] vs. 23.0% [18.4-28.1] vs. 24.8% [19.6-27.4]; p<0.001) and beta (34.7% [27.7-42.3] vs. 
39.9% [34.5-45.1] vs. 39.5% [35.6-42.9]; p=0.001) activities (Table 2).   
 
There were significant topographical differences between spectral variables in the patients with cirrhosis, in 
relation to their neuropsychiatric status (Figure 1; Supplementary Table 1).  The most prominent overall 
feature was anteriorisation and dissociation of the posterior basic alpha rhythm and its gradual replacement 
with theta activity, and later delta activity, as the degree of neuropsychiatric impairment increased.  In 
addition, the beta activity increased symmetrically in the frontal and temporal areas in the 
neuropsychiatrically unimpaired patients and those with minimal HE, but was comparable to reference 
values in the patients with overt HE.  
 
Beta activities were significantly higher in the patients with alcohol-related cirrhosis than in their non-
alcohol-related counterparts (39.6% [34.5-44.5] vs. 34.4% [29.2-40.6]; (p<0.001), otherwise there were no 
significant differences in frequency estimates between patient subgroups in relation to disease aetiology. 
This difference remained significant after stratification of patients by disease aetiology and 
neuropsychiatric status (Table 3). 
 
 
EEG variability analysis 
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Coefficient of variation: The median average CV was significantly reduced in the patients with cirrhosis 
compared to the healthy controls (21.2% [19.3-23.4] vs. 22.4% [20.8-24.5]; p<0.001) (Table 2).  This 
reflected a reduction in median EEG variability in the patients with overt HE.  The median average CV was 
significantly reduced in the patients with alcohol-related cirrhosis compared to the healthy controls but the 
results in the non-alcohol-related cirrhosis and the healthy controls were comparable (Table 3). 
 
Sample entropy: There was no significant difference in the median average sample entropy between the 
patients with cirrhosis and the healthy controls (0.84 [0.74-1.00] vs.0.91 [0.78-1.00]; p=0.1).  However, 
median average sample entropy was significantly increased in the patients with minimal HE (0.98 [0.87-
1.14]) compared to both the unimpaired patients (0.83 [0.75-0.95]; p=0.02), and the patients with overt HE 
(0.82 [0.71-1.01] p=0.01) (Table 2).  Median average sample entropy was reduced in patients with non 
alcohol-related cirrhosis compared to both the reference population (0.77 [0.67-0.95] vs. 0.91 [0.78-1.00]; 
p=0.01) and the patients with alcohol-related cirrhosis (0.77 [0.67-0.95] vs. 0.85 [0.77-1.01]; p=0.02) 
(Table 3).   
 
Associated variables: The presence of clinical HE was significantly associated with average CV on 
univariate analysis (coefficient = 0.002; p= 0.019) while the aetiology of the liver disease was significantly 
associated with average sample entropy (coefficient=-0.099; p=0.008).  Multivariate analysis confirmed the 
independence and significance of these associations viz. average CV and the presence of clinical HE 
(coefficient=0.003; p=0.007); aetiology of the liver disease and sample entropy (coefficient=-0.095; 
p=0.011).   
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Discussion  
 
Variability of the EEG was identified, in this study, as a novel feature associated with both the presence and 
severity of HE; increased variability was observed in patients with minimal HE, whereas in patients with 
overt HE the EEG there was a loss of variability.  The relationship of the EEG variability was more 
complex; the average CV was significantly reduced in patients with alcohol-related cirrhosis whereas the 
average sample entropy was significantly reduced in the patients with non-alcohol-related cirrhosis; 
multivariate analysis confirmed that non-alcohol-related cirrhosis was significantly and independently 
associated with sample entropy but did not confirm the independence of the relationship between alcohol-
related cirrhosis and CV.  In addition, and in agreement with other studies, the presence of HE was 
characterised by slowing of the brain rhythmicity and anteriorisation of the posterior basal rhythm. 
 
Spectral EEG estimates  
Slowing of the EEG with anteriorisation of the posterior basal rhythm was observed with increasing 
severity of neuropsychiatric impairment, confirming previous reports based on visual, semi-quantitative and 
automated EEG analysis [11,24–27]. However although this finding is characteristic of HE, it is not 
specific as it is also seen in other conditions of reduced vigilance e.g. in the transitional wake/sleep phase 
[28].  
 
In addition to the generalized slowing of the EEG there was evidence of an increase in fast beta activity in 
the patients with alcohol-related disease.  Increased beta power has been documented in the resting EEG in 
30 to 50% of alcohol dependent individuals [2, 32], and has been attributed to changes in gamma 
aminobutyric acid (GABA) neurotransmission.  Variations in the GABA alpha-2 gene (GABRA2) are 
strongly associated with the beta frequency of the human electroencephalogram (EEG) [29].  Genetic 
studies in humans have provided evidence of involvement of the GABA system in the susceptibility to 
develop alcohol dependence through an affect on the level of neural excitability[30].  However, alcohol per 
se modulates GABAergic neurotransmission resulting in an increase in the beta activity in the EEG.   Thus, 
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the increase in beta activity in the EEG in these patients may represent either a trait marker of a 
dysfunctional gamma aminobutyric acid (GABA) system or a state marker of ongoing alcohol misuse 
[31,32].  None of the patients with alcohol-related cirrhosis in the present study had misused alcohol for a 
minimum of three months before the study.  Equally the increase in the beta activity could not be ascribed 
to an excess of patients with minimal HE within this group as the distribution of patients by 
neuropsychiatric status did not differ by disease aetiology.  Thus, the increase in beta activities observed in 
patients with alcohol-related cirrhosis most likely represents a trait marker of dysfunctional GABAergic 
neurotransmission.  This, then is an important confounder which should be taken into account when 
interpreting the EEG in patients being screened for minimal HE. 
 
In patients with cirrhosis, spectral estimates of the EEG have traditionally been applied for diagnostic 
purposes based on somewhat artificial derived thresholds [11,24,27].  However, the neuropsychiatric 
changes associated with HE are much more likely to represent a continuum with no natural thresholds or 
stages [1].  Thus, use of simple diagnostic thresholds may result in over- or under diagnosis of the condition 
and should be applied and interpreted with caution.  In the present study a descriptive analysis of EEG was 
adopted to identify distinct electrophysiological signatures of the brain dysfunction, rather than focusing on 
thresholds for diagnostic purposes.  The agreement between the EEG characteristics and patients 
categorized using conventional clinical and psychometric criteria was not absolute, which was to be 
expected as each modality accesses different domains of cerebral activity.  The findings in the present study 
are echoed in a recent study of brain networks in patients with cirrhosis using functional magnetic 
resonance imaging and graph theoretical analysis, which showed that changes in cerebral networks were 
evident before the advent of either clinical changes suggestive of HE or disturbed psychometric 
performance [33].  Taken together, the newly derived EEG parameters [mym1]may identify abnormal cortical 
processing at an earlier stage than current available psychometric methods and, as such, they may be useful 
for its earlier identification.   Whether such ’early identification‘, translates to better prognostic accuracy 
and improved patient outcome needs to be established in prospective studies.   
JHEPATOL-D-16-00282 R1  
15 
 
 
EEG variability  
Increased sample entropy of the EEG was observed in patients with minimal HE.  This has not previously 
been reported and, as such, may provide a new marker of brain dysfunction in this patient population.  In 
early studies, based on subjective analysis of the EEG, `low grade HE` was characterised by transient bursts 
of slow wave oscillations superimposed on the normal alpha dominated brain rhythm [6,34].  The increased 
sample entropy observed in patients with minimal HE, in the present study, may comprise an objective 
correlate of this early observation.  Accordingly, in the transition from an unimpaired mental state to overt 
HE the physiological brain rhythm, dominated by alpha activity, is gradually replaced by slowed brain 
oscillations typically within the theta frequency range (4-8 Hz) [27,35].  It could be speculated that bursts 
of theta activity in the early stages of HE interrupts the stability of the physiological alpha rhythm and 
thereby increases sample entropy of the EEG.  In keeping with this, variability would be expected to 
decrease in patients with overt HE and accompanying slowing ofas  brain rhythmicity slows, which is in 
agreement with the findings in the present studypresent findings.   
 
Increased bursts of theta activity in patients with cirrhosis may represent a neurophysiological hallmark of 
abnormal thalamocortical connectivity as suggested by in vitro and clinical studies of neurological and 
neuropsychiatric disorders [36,37].  Hence, increased low-frequency theta activities, in conjunction with a 
widespread and marked increase of coherence among high- and low-frequency oscillations, have been 
described in patients with neurogenic pain, tinnitus, Parkinson's disease, and depression [37].  Interestingly, 
central lateral thalamotomy normalise the EEG and symptoms in patients with neurogenic pain, which 
underlines the importance of abnormal thalamocortical interplay in these patients [38].  However, further 
studies are needed to understand the importance of thalamocortical dysrhythmia in the context of the 
neuropsychological abnormalities that arise in patients with cirrhosis.  
 
The pathophysiology underlying the changes in EEG variability and its association with HE were not 
addressed in the present study.  Suppressed dynamics of other biological systems e.g. heart rate variability 
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are associated with disorders of neuropsychiatric dysfunction including HE [39–42].  Interestingly, the 
change in heart rate variability, and the association with HE observed in patients with cirrhosis, was related 
to an overproduction of inflammatory cytokines, thus suggesting a dysregulatedderegulated inflammatory 
response as a common pathogenic mechanism [39].  Future studies are needed to understand the complex 
interactions across biological systems in patients with cirrhosis and to further characterise their mediators. 
 
Study strengths and limitations 
This study was undertaken in a large group of well-characterized patients with cirrhosis and varying 
degrees of HE.  The large sample size allowed for detailed stratification and analysis of factors associated 
with changes in EEG estimates and, in addition to neuropsychiatric status, a number of other possible 
confounding variables including age, gender and the severity and aetiology of the liver injury - albeit the 
absolute contributions of these factors were minor compared with the contribution from the alterations in 
neuropsychiatric status.   
 
The loss of variability in physiological systems is a negative predictor of outcome [13, 40-42].  
However, although the presence of overt HE was shown to be associated with a significant loss of 
EEG variability the association with disease outcome was not explored in the present study.  
 
Conclusions 
Electroencephalogram variability is suppressed in patients with cirrhosis and overt HE, while patients with 
minimal HE are characterized by increased EEG variability. These novel findings may represent distinct 
markers of brain dysfunction in patients with cirrhosis and provide new insight to the intricate brain 
dysfunction complicating this entity.  
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Table 1: Demographic and assessment variables in the reference and patient populations, by neuropsychiatric status 
 
 
Data are expressed as mean ± 1SD (range) or absolute number (%) 
 
HE: hepatic encephalopathy; MELD: model for end-stage liver disease; NCT-A/B, Number Connection Tests A/B; DS: Digit Symbol Test; LT-T/E: Line Tracing Test-
Time/Error; SD: Serial Dotting Test; PHES Psychometric Hepatic Encephalopathy Score  
 
&PHES score range for UK identification cohort is standardized so the original normative dataset had a mean of zero and a SD of one 
 
Significance of the difference between the reference population and the various patient subgroups; ^ p<0.05; ^^ p<0.01; ^^^ p<0.001; ^^^^ p<0.0001 
Significance of the difference between unimpaired patients and those with minimal/overt HE; * p < 0.05; ** p<0.01; *** p<0.001; **** P<0.0001  
Significance of the difference between patients with minimal and overt HE; # p < 0.05; ## p<0.01; ### p<0.001; #### p<0.0001  
 
 
 
 
 
 
 
 
Study population  
(n) 
Age 
(yr) 
Gender  
(% men) 
MELD score 
 
DS 
(n correct) 
NCTA 
(s) 
NTCB 
(s) 
SD 
(s) 
LTT 
(s) 
LTE 
(n errors) 
 
PHES 
score& 
Reference population (137) 
39.2±16.0 
(17-54) 
53 
 
        
All patients with cirrhosis: (226) 
54.8±10.0^^^^ 
(26-80) 
 
 66^ 
 
12.0±5.1 
(6-34) 
34.5±13.7 
(0:80) 
56.1±49.7 
(16:480) 
151.4±105.7 
(22:480) 
70.6±37.2 
(29:332) 
102.4±56.2 
(25:431) 
64.6±61.8 
(0:389) 
-1.5±1.5 
(-7:2) 
Unimpaired (127) 
54.1±9.5^^^  
(32-80) 
65 
 
10.4±4.1 
(6-30) 
42.2±10.7 
(21-80) 
 
37.1±13.7 
(16-87) 
 
98.7±55.5 
(22-400) 
 
54.6±17.2 
(29-111) 
 
82.2±35.1 
(25-213) 
 
48.9±40.5 
(2-197) 
 
-0.6±0.9 
(-2: +2) 
 
Minimal HE (21) 
56.1±7.8^^^  
(42-71) 
67 
 
10.3±2.7 
(6-15) 
 
25.0±9.9***  
(0-40) 
 
67.4±25.3*** 
(36-148) 
 
213.2±116.6*** 
(73-480) 
 
77.3±21.3***  
(48-138) 
 
117.4±43.4*** 
(67-230) 
 
71.8±63.5 
(5-204) 
 
-2.6±0.5*** 
(-4:-2) 
 
Overt HE (78) 
55.5±11.2^^^ 
(26-78) 
68^ 
 
15.2±5.4***###  
(6-34) 
 
24.4±10.3***  
(3-45) 
 
83.9±72.9***  
(24-480) 
 
220.7±116.6*** 
(55-480) 
 
94.8±49.2***  
(35-332) 
 
131.4±71.5*** 
(39-431) 
 
88.2±80.2***  
(0-389) 
 
-2.8±1.4*** 
(-7: 0) 
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Table 2: Spectral EEG indices, coefficient of variation and sample entropy in the reference population and patients with cirrhosis, 
by neuropsychiatric status 
Data are expressed as median (interquartile range)  
 
Dunn's Pairwise Comparison test with the Bonferroni corrections for multiple comparisons: 
Significance of the difference between the reference population and the various patient subgroups; ^ p<0.05; ^^ p<0.01; ^^^ p<0.001; ^^^^ p<0.0001 
Significance of the difference between unimpaired patients and those with minimal/overt HE; * p < 0.05; ** p<0.01; *** p<0.001; **** P<0.0001  
Significance of the difference between patients with minimal and overt HE; # p < 0.05; ## p<0.01; ### p<0.001; #### p<0.0001  
 
 
 
Study Population 
(n) 
Delta 
(%) 
Theta 
(%) 
Alpha 
(%) 
Beta 
(%) 
CV 
(%) 
Sample Entropy 
Reference population (137) 20.4 (17.6-24.8) 15.2 (13.6-17.0) 23.2 (18.0-28.9) 39.5 (34.7-43.7) 22.4 (20.8-24.5) 0.91 (0.78-1.00) 
       
All patients with cirrhosis: (226) 19.8 (17.0-23.5) 16.8 (14.1-21.4)^^^^ 21.4 (16.9-26.3)^ 38.4 (32.9-44.5) 21.2 (19.3-23.4)^^^ 0.84 (0.74-1.00) 
       
Unimpaired (127) 19.6 (16.8-22.8) 15.4 (13.6-18.0) 23.0 (18.4-28.1) 39.9 (34.5-45.1) 21.6 (20.0-24.0) 0.83 (0.75-0.95) 
       
Minimal HE (21) 19.8 (16.5-22.9) 16.3 (13.6-17.5) 24.8 (19.6-27.4) 39.5 (35.6-42.9) 22.1 (19.3-25.6) 0.98 (0.87-1.14)* 
       
Overt HE (78) 20.7 (17.9-27.5) 22.9 (17.1-27.6)^^^^****### 18.7 (15.6-22.4)^^^^***# 34.7 (27.7-42.3)^^*** 20.3 (18.4-22.2)^^^^* 0.82 (0.71-1.01)## 
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Table 3: Spectral EEG indices, coefficient of variation and sample entropy in the reference population and patients with cirrhosis,  
Study population 
(n)& 
      Delta 
        (%) 
      Theta 
        (%) 
     Alpha 
       (%) 
     Beta 
      (%) 
     CV 
     (%) 
Sample Entropy 
Reference population (137) 20.4 (17.6-24.8) 15.2 (13.6-17.0) 23.2 (18.0-28.9) 39.5 (34.7-43.7) 22.4 (20.8-24.5) 0.91 (0.78-1.00) 
Alcohol related cirrhosis (157)       
     Unimpaired (93) 19.8 (16.9 - 22.7) 15.5 (13.6 - 17.8) 22.9 (18.4 - 27.0) 39.7 (35.3 - 45.6) 21.6 (19.9 - 23.4) 0.84 (0.77 – 0.95) 
     Minimal HE (12) 21.1 (16.0 - 25.1) 15.5 (13.3 - 17.0) 21.5 (16.8 - 27.6) 40.6 (38.6 - 45.5) 22.2 (19.2 - 24.6) 1.01 (0.90 - 1.15) 
     Overt HE (52) 19.1 (17.6 – 23.0) 21.6 (17.0 – 25.9)^^^^ 18.3 (15.4 – 22.7)^^^ 36.8 (31.0 – 43.0) 20.3 (18.3 – 22.3)^^^ 0.84 (0.75 – 1.03) 
Non-alcohol-related cirrhosis (48)       
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 by aetiology of liver disease and neuropsychiatric status 
Data are expressed as median (interquartile range)  
 
&Patients with alcohol-related cirrhosis and co-morbid Hepatitis B or Hepatitis C infection were omitted from the analysis (n=21) 
 
Dunn's Pairwise Comparison test with the Bonferroni corrections for multiple comparisons: 
Significance of the difference between the reference population and the various patient subgroups; ^ p<0.05; ^^ p<0.01; ^^^ p<0.001; ^^^^ p<0.0001 
 
Mann-Whitney U test:  
Significance of the difference between patients with alcohol related cirrhosis and those with non-alcohol related cirrhosis stratified by neuropsychiatric status;     
* p < 0.05; ** p<0.01; *** p<0.001; **** P<0.0001  
     Unimpaired (21) 19.6 (15.7 – 22.8) 15.5 (14.1 – 18.3) 25.3 (20.9 – 31.8) 35.1 (32.3 – 42.9) 22.1 (20.3 – 25.9) 0.78 (0.69 – 0.92)* 
     Minimal HE (7) 19.8 (17.7 – 22.4) 19.0 (15.5 – 23.2) 24.8 (19.6 – 27.1) 35.5 (33.0 – 40.2) 24.0 (20.4 – 29.5) 0.90 (0.73 – 1.00) 
     Overt HE (20) 27.1 (18.3 – 31.6)* 25.8 (17.6 – 31.1)^^^^ 19.6 (16.6 – 23.4) 29.2 (23.9 -38.2)^^^* 21.3 (19.0 – 22.9) 0.76 (0.64 – 0.98) 
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Legends to Figures 
 
Figure 1. Average head maps showing the spatial distributions of spectral EEG indices in the 
reference population (n=137) and in the patients with cirrhosis (n=226), by neuropsychiatric status. 
 
The most prominent feature is the gradual loss of the alpha rhythm, as the degree of neuropsychiatric 
impairment increases, and its replacement with theta and subsequently delta activity.  In addition, the beta 
activity increases symmetrically in the frontal and temporal areas in the neuropsychiatrically unimpaired 
patients and in those with minimal HE, but this increase is attenuated in patients with overt HE. 
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